Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study
- 19 March 2024
- journal article
- letter
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (1) , 141-142
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective StudyCureus, 2023
- The uses of naltrexone in dermatologic conditionsJournal of the American Academy of Dermatology, 2019
- Frontal fibrosing alopecia: efficacy of treatment modalitiesInternational Journal of Women's Health, 2019
- Prognosis, treatment, and disease outcomes in frontal fibrosing alopecia: A retrospective review of 92 casesJournal of the American Academy of Dermatology, 2018